Sp1 Controls the Basal Level of Interleukin-34 Transcription

References

• Al-Shaebi F, Wenzhang L, Hezam K, Almezgagi M, Wei L. 2020. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases. Int Immunopharmacol. 89(Pt B):107023.
   PubMedGoogle Scholar
• Baghdadi M, Endo H, Takano A, Ishikawa K, Kameda Y, Wada H, Miyagi Y, Yokose T, Ito H, Nakayama H, Daigo Y. 2018. High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers. Sci Rep. 8(1):418.
   PubMedGoogle Scholar
• Baghdadi M, Endo H, Tanaka Y, Wada H, Seino KI. 2017. Interleukin 34, from pathogenesis to clinical applications. Cytokine. 99:139–47.
   PubMed Web of Science ®Google Scholar
• Baghdadi M, Umeyama Y, Hama N, Kobayashi T, Han N, Wada H, Seino KI. 2018. Interleukin-34, a comprehensive review. J Leukoc Biol. 104(5):931–51.
   PubMed Web of Science ®Google Scholar
• Beishline K, Azizkhan-Clifford J. 2015. Sp1 and the ‘hallmarks of cancer’. FEBS J. 282(2):224–58.
   PubMed Web of Science ®Google Scholar
• Berrier A, Siu G, Calame K. 1998. Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells. J Immunol. 161(5):2267–75.
   PubMed Web of Science ®Google Scholar
• Bostrom EA, Lundberg P. 2013. The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. Plos One. 8(12):e81665.
   PubMed Web of Science ®Google Scholar
• Canaff L, Zhou X, Hendy GN. 2008. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J Biol Chem. 283(20):13586–600.
   PubMed Web of Science ®Google Scholar
• Chang E-J, Lee SK, Song YS, Jang YJ, Park HS, Hong JP, Ko AR, Kim DY, Kim J-H, Lee YJ, Heo Y-S. 2014. IL-34 is associated with obesity, chronic inflammation, and insulin resistance. J Clin Endocrinol Metab. 99(7):E1263–71.
   PubMed Web of Science ®Google Scholar
• Chemel M, Brion R, Segaliny A-I, Lamora A, Charrier C, Brulin B, Maugars Y, Le Goff B, Heymann D, Verrecchia F. 2017. Bone morphogenetic protein 2 and transforming growth factor β1 inhibit the expression of the proinflammatory cytokine IL-34 in rheumatoid arthritis synovial fibroblasts. Am J Pathol. 187(1):156–62.
   PubMed Web of Science ®Google Scholar
• Chhetri G. 2021. Emerging roles of IL-34 in neurodegenerative and neurological infectious disease. Int J Neurosci. 1–12. doi:10.1080/00207454.2021.1963962.
   PubMed Web of Science ®Google Scholar
• Chihara T, Suzu S, Hassan R, Chutiwitoonchai N, Hiyoshi M, Motoyoshi K, Okada S. 2010. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 17(12):1917–27.
   PubMed Web of Science ®Google Scholar
• Choi ES, Nam JS, Jung JY, Cho NP, Cho SD. 2014. Modulation of specificity protein 1 by mithramycin a as a novel therapeutic strategy for cervical cancer. Sci Rep. 4(1):7162.
   PubMedGoogle Scholar
• Ciccia F, Alessandro R, Rodolico V, Guggino G, Raimondo S, Guarnotta C, Triolo G, Sireci G, Campisi G, De Leo G, et al. 2013. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren’s syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes. Rheumatol (Oxford). 52(6):1009–17.
   PubMed Web of Science ®Google Scholar
• Deaton AM, Bird A. 2011. CpG islands and the regulation of transcription. Genes Dev. 25(10):1010–22.
   PubMed Web of Science ®Google Scholar
• Eda H, Shimada H, Beidler DR, Monahan JB. 2010. Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts. Rheumatol Int. 31(11):1525–30.
   PubMed Web of Science ®Google Scholar
• Esaki H, Ewald DA, Ungar B, Rozenblit M, Zheng X, Xu H, Guttman-Yassky E. 2015. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. J Allergy Clin Immunol. 135(1):153–63.
   PubMed Web of Science ®Google Scholar
• Fan Q, Yan X, Zhang H, Lu L, Zhang Q, Wang F, Xi R, Hu J, Chen Q, Niu W, et al. 2016. IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure. Sci Rep. 6(1):39324.
   PubMedGoogle Scholar
• Franzè E, Monteleone I, Cupi ML, Mancia P, Caprioli F, Marafini I, Colantoni A, Ortenzi A, Laudisi F, Sica G, et al. 2015. Interleukin-34 sustains inflammatory pathways in the gut. Clin Sci. 129(3):271–80.
   PubMed Web of Science ®Google Scholar
• Franze E, Stolfi C, Troncone E, Scarozza P, Monteleone G. 2020. Role of interleukin-34 in cancer. Cancers (Basel). 12(1):252.
   PubMed Web of Science ®Google Scholar
• Freuchet A, Salama A, Remy S, Guillonneau C, Anegon I. 2021. IL-34 and CSF-1, deciphering similarities and differences at steady state and in diseases. J Leukoc Biol. 110(4):771–96.
   PubMed Web of Science ®Google Scholar
• Ge Y, Huang M, Yao YM. 2019. Immunomodulation of interleukin-34 and its potential significance as a disease biomarker and therapeutic target. Int J Biol Sci. 15(9):1835–45.
   PubMed Web of Science ®Google Scholar
• Ge Y, Huang M, Zhu XM, Yao YM. 2020. Biological functions and clinical implications of interleukin-34 in inflammatory diseases. Adv Protein Chem Struct Biol. 119:39–63.
   PubMed Web of Science ®Google Scholar
• Glogauer M, Boström EA, Lundberg P. 2013. The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. Plos One. 8(12):e81665.
   PubMed Web of Science ®Google Scholar
• Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, Kündig T, Frei K, Ginhoux F, Merad M, et al. 2012. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity. 37(6):1050–60.
   PubMed Web of Science ®Google Scholar
• Huang C, Xie K. 2012. Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth Factor Rev. 23(1–2):25–35.
   PubMed Web of Science ®Google Scholar
• Ivanenko KA, Prassolov VS, Khabusheva ER. 2022. Transcription factor Sp1 in the expression of genes encoding components of MAPK, JAK/STAT, and PI3K/Akt signaling pathways. Mol Biol (Mosk). 56(5):832–47.
   PubMed Web of Science ®Google Scholar
• Jankowski JM, Dixon GH. 1987. The GC box as a silencer. Biosci Rep. 7(12):955–63.
   PubMed Web of Science ®Google Scholar
• Jiang J-F, Zhou Z-Y, Liu Y-Z, Wu L, Nie B-B, Huang L, Zhang C. 2022. Role of Sp1 in atherosclerosis. Mol Biol Rep. 49(10):9893–902.
   PubMed Web of Science ®Google Scholar
• Khoshnan A, Sabbaugh A, Calamini B, Marinero SA, Dunn DE, Yoo JH, Patterson PH, Lo DC, Patterson PH. 2017. IKKβ and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD. Hum Mol Genet. 26(21):4267–77.
   PubMed Web of Science ®Google Scholar
• Lelios I, Cansever D, Utz SG, Mildenberger W, Stifter SA, Greter M 2020. Emerging roles of IL-34 in health and disease. J Exp Med. 217(3). doi:10.1084/jem.20190290.
   PubMed Web of Science ®Google Scholar
• Li M, Dong Y, Chen Z, Meng L, Liu X, Zhang X, Wang H, Mao W, Zhang J, Jiang Z, Huang T. 2019. MicroRNA-31 negatively regulates interleukin-34 expression in vitro. Immunol Invest. 48(6):597–607.
   PubMed Web of Science ®Google Scholar
• Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, Halenbeck R, Wu G, Zhou A, Behrens D, et al. 2008. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science. 320(5877):807–11.
   PubMed Web of Science ®Google Scholar
• Liu H, Leo C, Chen X, Wong BR, Williams LT, Lin H, He X. 2012. The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. Biochim Biophys Acta (BBA) - Proteins Proteomics. 1824(7):938–45.
   PubMed Web of Science ®Google Scholar
• Moon SJ, Hong YS, Ju JH, Kwok SK, Park SH, Min JK. 2013. Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis. J Rheumatol. 40(11):1842–49.
   PubMed Web of Science ®Google Scholar
• Nandi S, Cioce M, Yeung YG, Nieves E, Tesfa L, Lin H, Hsu AW, Halenbeck R, Cheng H-Y, Gokhan S, et al. 2013. Receptor-type protein-tyrosine phosphatase ζ is a functional receptor for interleukin-34. J Biol Chem. 288(30):21972–86.
   PubMed Web of Science ®Google Scholar
• O’Connor L, Gilmour J, Bonifer C. 2016. The role of the ubiquitously expressed transcription factor Sp1 in tissue-specific transcriptional regulation and in disease. Yale J Biol Med. 89(4):513–25.
   PubMedGoogle Scholar
• Otsuka R, Wada H, Seino KI. 2021. IL-34, the rationale for its expression in physiological and pathological conditions. Semin Immunol. 54:101517.
   PubMed Web of Science ®Google Scholar
• Ratajewski M, Slomka M, Karas K, Sobalska-Kwapis M, Korycka-Machala M, Salkowska A, Dastych J, Strapagiel D, Dastych J. 2017. Functional analysis of the rs774872314, rs116171003, rs200231898 and rs201107751 polymorphisms in the human RORgammaT gene promoter region. Genes (Basel). 8(4):126.
   PubMed Web of Science ®Google Scholar
• Resendes KK, Rosmarin A. 2004. Sp1 control of gene expression in myeloid cells. Crit Rev Eukaryot Gene Expr. 14(3):171–81.
   PubMed Web of Science ®Google Scholar
• Samson SL, Wong NC. 2002. Role of Sp1 in insulin regulation of gene expression. J Mol Endocrinol. 29(3):265–79.
   PubMed Web of Science ®Google Scholar
• Segaliny AI, Brion R, Mortier E, Maillasson M, Cherel M, Jacques Y, Le Goff B, Heymann D. 2015. Syndecan-1 regulates the biological activities of interleukin-34. Biochim Biophys Acta (BBA) - Mol Cell Res. 1853(5):1010–21.
   PubMed Web of Science ®Google Scholar
• Segaliny AI, Mohamadi A, Dizier B, Lokajczyk A, Brion R, Lanel R, Heymann D, Charrier C, Boisson-Vidal C, Heymann D. 2015. Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. Int J Cancer. 137(1):73–85.
   PubMed Web of Science ®Google Scholar
• Shoji H, Yoshio S, Mano Y, Kumagai E, Sugiyama M, Korenaga M, Arai T, Itokawa N, Atsukawa M, Aikata H, et al. 2016. Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep. 6(1):28814.
   PubMedGoogle Scholar
• Tao R, Fan Q, Zhang H, Xie H, Lu L, Gu G, Wang F, Xi R, Hu J, Chen Q, et al. 2017. Prognostic significance of interleukin-34 (IL-34) in patients with chronic heart failure with or without renal insufficiency. J Am Heart Assoc. 6(4). doi:10.1161/JAHA.116.004911.
   PubMed Web of Science ®Google Scholar
• Tian Y, Shen H, Xia L, Lu J. 2013. Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production. J Interferon Cytokine Res. 33(7):398–401.
   PubMed Web of Science ®Google Scholar
• Tone M, Tone Y, Babik JM, Lin CY, Waldmann H. 2002. The role of Sp1 and NF-kappa B in regulating CD40 gene expression. J Biol Chem. 277(11):8890–97.
   PubMed Web of Science ®Google Scholar
• Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima T, Kawamoto S, Ishigatsubo Y, Okubo T. 1994. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol. 153(5):2052–63.
   PubMed Web of Science ®Google Scholar
• Vellingiri B, Iyer M, Devi Subramaniam M, Jayaramayya K, Siama Z, Giridharan B, Cho SG. 2020. Understanding the role of the transcription factor Sp1 in ovarian cancer: from theory to practice. Int J Mol Sci. 21(3):1153.
   PubMed Web of Science ®Google Scholar
• Vizcaino C, Mansilla S, Portugal J. 2015. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 152:111–24.
   PubMed Web of Science ®Google Scholar
• Walker DG, Tang TM, Lue LF. 2017. Studies on colony stimulating factor receptor-1 and ligands colony stimulating factor-1 and interleukin-34 in Alzheimer’s disease brains and human microglia. Front Aging Neurosci. 9:244.
   PubMed Web of Science ®Google Scholar
• Wang YQ, Cao WJ, Gao YF, Ye J, Zou GZ. 2018. Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol. 24(12):1312–20.
   PubMed Web of Science ®Google Scholar
• Wang H, Cao J, Lai X. 2016. Serum interleukin-34 levels are elevated in patients with systemic lupus erythematosus. Molecules. 22(1):35.
   PubMed Web of Science ®Google Scholar
• Wang Y, Colonna M. 2014. Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and langerhans cells. Eur J Immunol. 44(6):1575–81.
   PubMed Web of Science ®Google Scholar
• Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, Barrow AD, Diamond MS, Colonna M. 2012. IL-34 is a tissue-restricted ligand of CSF1R required for the development of langerhans cells and microglia. Nat Immunol. 13(8):753–60.
   PubMed Web of Science ®Google Scholar
• Wang B, Xu W, Tan M, Xiao Y, Yang H, Xia T-S. 2015. Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction. Int J Mol Med. 35(1):92–102.
   PubMed Web of Science ®Google Scholar
• Xie HH, Shen H, Zhang L, Cui MY, Xia LP, Lu J. 2018. Elevated serum interleukin-34 level in patients with systemic lupus erythematosus is associated with disease activity. Sci Rep. 8(1):3462.
   PubMedGoogle Scholar
• Xu WD, Huang AF, Fu L, Liu XY, Su LC. 2019. Targeting IL-34 in inflammatory autoimmune diseases. J Cell Physiol. 234(12):21810–16.
   PubMed Web of Science ®Google Scholar
• Yu Y, Yang D, Qiu L, Okamura H, Guo J, Haneji T. 2014. Tumor necrosis factor-alpha induces interleukin-34 expression through nuclear factorkappaB activation in MC3T3-E1 osteoblastic cells. Mol Med Rep. 10(3):1371–76.
   PubMed Web of Science ®Google Scholar
• Zhang D, Li M, Dong Y, Zhang X, Liu X, Chen Z, Shen Y, Wang H, Liu X, Zhu J, et al. 2017. 1α,25-dihydroxyvitamin D3 up-regulates IL-34 expression in SH-SY5Y neural cells. Innate Immun. 23(7):584–91.
   PubMed Web of Science ®Google Scholar
• Zwicker S, Martinez GL, Bosma M, Gerling M, Clark R, Majster M, Söderman J, Almer S, Boström E. 2015. Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clin Sci (Lond). 129(3):281–90.
   PubMed Web of Science ®Google Scholar